{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:26:50Z","timestamp":1790015210564,"version":"4.0.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005279","name":"Universidade Federal Do Piau\u00ed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005279","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The fasting-mimicking diet (FMD) is a plant-based, low-calorie dietary intervention characterized by reduced carbohydrate, with an emphasis on complex carbohydrates, and protein intake, alongside increased fat intake, designed to replicate the metabolic effects of fasting. Increasing evidence suggests that FMD may modulate tumorigenic pathways, enhancing the efficacy of anticancer treatments while minimizing adverse effects and resistance. This systematic review aimed to evaluate the effects of FMD on tumor metabolism, both as a standalone intervention and in combination with conventional and experimental therapies, and to identify the underlying mechanisms involved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review was registered in PROSPERO and conducted according to PRISMA guidelines. A comprehensive search of Embase, PubMed\/MEDLINE, Scopus, Web of Science, and Science Direct was performed using the term \u201cfasting-mimicking diet.\u201d Inclusion criteria comprised preclinical studies in mice or rats that implemented\u2009\u2265\u200950% caloric restriction and assessed the impact of FMD on tumorigenesis rate, tumor count, volume or weight, survival rate, inflammatory and immune responses, oxidative stress, gene\/protein expression linked to antitumor effects, or treatment-related toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FMD alone was associated with delayed tumor progression, reduced metastasis, and downregulation of tumor-promoting biomarkers. When combined with chemotherapy, hormone therapy, targeted therapy, immunotherapy, or vitamin C, FMD enhanced antitumor efficacy through mechanisms involving oxidative stress modulation, improved antioxidant activity, autophagy regulation, and immune and inflammatory responses. These pathways contribute to the differential stress resistance observed in normal cells and increased vulnerability in tumor cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preclinical evidence suggests it can suppress tumor growth, reduce metastatic burden, and potentiate the therapeutic effects of multiple treatment modalities by modulating key metabolic pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00394-026-03891-2","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:14:01Z","timestamp":1770884041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fasting-mimicking diets as a strategy to reprogram tumor metabolism: a systematic review"],"prefix":"10.1007","volume":"65","author":[{"given":"Irislene Costa","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorddam Almondes","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallyla Jennifer Morais","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Shelda","family":"de Oliveira Neres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Soares Pereira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheniffer","family":"da Silva Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Lima","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Cavalcanti Carneiro","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Soares","family":"Severo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Leonardo","family":"Torres-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"3891_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1158\/1055-9965.EPI-22-1133","volume":"32","author":"E Sedeta","year":"2023","unstructured":"Sedeta E, Sung H, Laversanne M, Bray F, Jemal A (2023) Recent mortality patterns and time trends for the major cancers in 47 countries worldwide. Cancer Epidemiol Biomarkers Prev 32:894\u2013905","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3891_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4:47\u201353","journal-title":"J Natl Cancer Cent"},{"key":"3891_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tem.2024.02.008","volume":"35","author":"Y Kim","year":"2024","unstructured":"Kim Y, Jang Y, Kim MS, Kang C (2024) Metabolic remodeling in cancer and senescence and its therapeutic implications. Trends Endocrinol Metab 35:744","journal-title":"Trends Endocrinol Metab"},{"key":"3891_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y (2024) Cancer metabolism and carcinogenesis. Exp Hematol Oncol 13:10","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"3891_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347","journal-title":"Cell Metab"},{"issue":"3","key":"3891_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00432-020-03155-4","volume":"146","author":"L Xing","year":"2020","unstructured":"Xing L et al (2020) A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 146(3):621\u2013630","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3891_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10999-9","volume":"23","author":"M Trajkovic-Arsic","year":"2023","unstructured":"Trajkovic-Arsic M, Subramani E (2023) Is metabolism the magic bullet for targeted cancer therapy? BMC Cancer 23(1):484","journal-title":"BMC Cancer"},{"issue":"3","key":"3891_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/cancers15030703","volume":"15","author":"M Sirico","year":"2023","unstructured":"Sirico M, D\u2019Angelo A, Gianni C, Casadei C, Merloni F, De Giorgi U et al (2023) Current state and future challenges for PI3K inhibitors in cancer therapy. Cancers (Basel) 15(3):703","journal-title":"Cancers (Basel)"},{"key":"3891_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cancerbio-030518-055855","volume":"3","author":"MD Goncalves","year":"2019","unstructured":"Goncalves MD, Hopkins BD, Cantley LC (2019) Dietary fat and sugar in promoting cancer development and progression. Annu Rev Cancer Biol 3:255\u2013273","journal-title":"Annu Rev Cancer Biol"},{"key":"3891_CR10","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","volume":"34","author":"BD Hopkins","year":"2016","unstructured":"Hopkins BD, Goncalves MD, Cantley LC (2016) Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol 34:4277\u20134283","journal-title":"J Clin Oncol"},{"key":"3891_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher EJ, LeRoith D (2020) Hyperinsulinaemia in cancer. Nat Rev Cancer 20:629\u2013644","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3891_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-8-54","volume":"8","author":"M Schmidt","year":"2011","unstructured":"Schmidt M, Pfetzer N, Schwab M, Strauss I, K\u00e4mmerer U (2011) Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (Lond) 8(1):54","journal-title":"Nutr Metab (Lond)"},{"key":"3891_CR13","doi-asserted-by":"publisher","first-page":"11806","DOI":"10.18632\/oncotarget.3688","volume":"6","author":"G Bianchi","year":"2015","unstructured":"Bianchi G, Martella R, Ravera S et al (2015) Fasting induces anti\u2010Warburg effect that increases respiration but reduces ATP\u2010synthesis to promote apoptosis in colon cancer models. Oncotarget 6:11806\u201311819","journal-title":"Oncotarget"},{"key":"3891_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1117701","volume":"3","author":"S Di Biase","year":"2016","unstructured":"Di Biase S, Longo VD (2016) Fasting\u2010induced differential stress sensitization in cancer treatment. Mol Cell Oncol 3:e1117701","journal-title":"Mol Cell Oncol"},{"key":"3891_CR15","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.clnu.2020.10.037","volume":"40","author":"M Sadeghian","year":"2021","unstructured":"Sadeghian M, Rahmani S, Khalesi S, Hejazi E (2021) A review of fasting effects on the response of cancer to chemotherapy. Clin Nutr 40:1669\u20131681","journal-title":"Clin Nutr"},{"key":"3891_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","volume":"12","author":"C Vernieri","year":"2022","unstructured":"Vernieri C, Ligorio F, Huber V et al (2022) Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Discov 12:90\u2013107","journal-title":"Cancer Discov"},{"issue":"21","key":"3891_CR17","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-23-0323","volume":"83","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Zhang H, Nan K et al (2023) Fasting-mimicking diet drives antitumor immunity against colorectal cancer by reducing IgA-producing cells. Cancer Res 83(21):3529\u20133543","journal-title":"Cancer Res"},{"issue":"7817","key":"3891_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","volume":"583","author":"I Caffa","year":"2020","unstructured":"Caffa I, Spagnolo V, Vernieri C et al (2020) Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583(7817):620\u2013624","journal-title":"Nature"},{"issue":"1","key":"3891_CR19","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s41467-020-16243-3","volume":"11","author":"M Di Tano","year":"2020","unstructured":"Di Tano M, Raucci F, Vernieri C et al (2020) Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nat Commun 11(1):2332","journal-title":"Nat Commun"},{"key":"3891_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104496","volume":"90","author":"X Liu","year":"2023","unstructured":"Liu X, Peng S, Tang G et al (2023) Fasting-mimicking diet synergizes with ferroptosis against quiescent, chemotherapy-resistant cells. EBioMedicine 90:104496","journal-title":"EBioMedicine"},{"key":"3891_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai8700","volume":"9","author":"M Wei","year":"2017","unstructured":"Wei M et al (2017) Fasting-mimicking diet and markers\/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 9:eaal8700","journal-title":"Sci Transl Med"},{"key":"3891_CR22","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1007\/s00125-021-05431-5","volume":"64","author":"SS Hammer","year":"2021","unstructured":"Hammer SS, Vieira CP, McFarland D, Sandler M, Levitsky Y, Dorweiler TF et al (2021) Fasting and fasting-mimicking treatment activate SIRT1\/LXR\u03b1 and alleviate diabetes-induced systemic and microvascular dysfunction. Diabetologia 64:1674\u20131689","journal-title":"Diabetologia"},{"key":"3891_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16138-3","volume":"11","author":"S de Groot","year":"2020","unstructured":"de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, Vreeswijk MPG et al (2020) Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun 11:3083","journal-title":"Nat Commun"},{"issue":"5","key":"3891_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051523","volume":"13","author":"AW Huang","year":"2021","unstructured":"Huang AW, Wei M, Caputo S, Wilson ML, Antoun J, Hsu WC (2021) An intermittent fasting mimicking nutrition bar extends physiologic ketosis in time restricted eating: a randomized, controlled, parallel-arm study. Nutrients 13(5):1523","journal-title":"Nutrients"},{"key":"3891_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111256","volume":"40","author":"S Cortellino","year":"2022","unstructured":"Cortellino S, Raveane A, Chiodoni C et al (2022) Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects. Cell Rep 40:111256","journal-title":"Cell Rep"},{"key":"3891_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"9","key":"3891_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/nutrit\/nuaa114","volume":"79","author":"JJA Ferguson","year":"2021","unstructured":"Ferguson JJA, Abbott KA, Garg ML (2021) Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 79(9):1043\u20131066","journal-title":"Nutr Rev"},{"key":"3891_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"3891_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1158\/0008-5472.CAN-23-0295","volume":"84","author":"F Raucci","year":"2024","unstructured":"Raucci F, Vernieri C, Di Tano M et al (2024) Cyclic fasting-mimicking diet plus bortezomib and rituximab is an effective treatment for chronic lymphocytic leukemia. Cancer Res 84(7):1133\u20131148","journal-title":"Cancer Res"},{"key":"3891_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115699","volume":"215","author":"W Huang","year":"2023","unstructured":"Huang W, Li X, Song H, Yin Y, Wang H (2023) Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models. Biochem Pharmacol 215:115699","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"3891_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gutjnl-2024-333020","volume":"74","author":"K Nan","year":"2025","unstructured":"Nan K, Zhong Z, Yue Y, Shen Y, Zhang H, Wang Z et al (2025) Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8+ T cells. Gut 74(5):775\u2013786","journal-title":"Gut"},{"issue":"1","key":"3891_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2016.06.005","volume":"30","author":"S Di Biase","year":"2016","unstructured":"Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng CW et al (2016) Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30(1):136\u2013146","journal-title":"Cancer Cell"},{"issue":"46","key":"3891_CR33","doi-asserted-by":"publisher","first-page":"25638","DOI":"10.1021\/acs.jafc.4c06475","volume":"72","author":"H Li","year":"2024","unstructured":"Li H, Li C, Ren M, Zhang F, Cao L, Ren K et al (2024) Fasting-mimicking diet prevents pancreatic carcinogenesis via gut microbiota and metabolites. J Agric Food Chem 72(46):25638\u201325647","journal-title":"J Agric Food Chem"},{"issue":"24","key":"3891_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245870","volume":"15","author":"R Buono","year":"2023","unstructured":"Buono R, Tucci J, Cutri R, Guidi N, Mangul S, Raucci F et al (2023) Fasting-mimicking diet inhibits autophagy and synergizes with chemotherapy to promote T-cell-dependent leukemia-free survival. Cancers (Basel) 15(24):5870","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3891_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26431-4","volume":"12","author":"LCD Pomatto-Watson","year":"2021","unstructured":"Pomatto-Watson LCD, Bodogai M, Bosompra O, Kato J, Wong S, Carpenter M et al (2021) Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition. Nat Commun 12(1):6201","journal-title":"Nat Commun"},{"issue":"6","key":"3891_CR36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.MCR-21-0781","volume":"20","author":"Q Zuo","year":"2022","unstructured":"Zuo Q, Mogol AN, Liu YJ, Santaliz Casiano A, Chien C, Drnevich J et al (2022) Targeting metabolic adaptations in the breast cancer-liver metastatic niche using dietary approaches to improve endocrine therapy efficacy. Mol Cancer Res 20(6):923\u2013937","journal-title":"Mol Cancer Res"},{"issue":"22","key":"3891_CR37","doi-asserted-by":"publisher","first-page":"9154","DOI":"10.1021\/acs.nanolett.2c03890","volume":"22","author":"R Qian","year":"2022","unstructured":"Qian R, Cao G, Su W, Zhang J, Jiang Y, Song H et al (2022) Enhanced sensitivity of tumor cells to autophagy inhibitors using fasting-mimicking. Nano Lett 22(22):9154\u20139162","journal-title":"Nano Lett"},{"issue":"1","key":"3891_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04577-7","volume":"21","author":"L Wang","year":"2023","unstructured":"Wang L, Wang YJ, Wang R, Gong FL, Shi YH, Li SN et al (2023) Fasting mimicking diet inhibits tumor-associated macrophage survival and pro-tumor function in hypoxia: implications for combination therapy with anti-angiogenic agent. J Transl Med 21(1):754","journal-title":"J Transl Med"},{"issue":"11","key":"3891_CR39","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.cmet.2021.10.008","volume":"33","author":"G Salvadori","year":"2021","unstructured":"Salvadori G, Zanardi F, Iannelli F, Lobefaro R, Vernieri C, Longo VD (2021) Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape. Cell Metab 33(11):2247-2259.e6","journal-title":"Cell Metab"},{"issue":"1","key":"3891_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00520-w","volume":"10","author":"M Luo","year":"2024","unstructured":"Luo M, Wang Q, Sun Y, Jiang Y, Wang Q, Gu Y et al (2024) Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression. NPJ Biofilms Microbiomes 10(1):53","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"12","key":"3891_CR41","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2015-12-684696","volume":"128","author":"Y Sumitomo","year":"2016","unstructured":"Sumitomo Y, Koya J, Nakazaki K, Kataoka K, Tsuruta-Kishino T, Morita K et al (2016) Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood 128(12):1614\u20131624","journal-title":"Blood"},{"key":"3891_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480:480\u2013489","journal-title":"Nature"},{"key":"3891_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2020","unstructured":"Jensen-Cody SO, Potthoff MJ (2020) Hepatokines and metabolism: deciphering communication from the liver. Mol Metab 44:101138","journal-title":"Mol Metab"},{"issue":"1","key":"3891_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J","volume":"183","author":"A Grimberg","year":"2000","unstructured":"Grimberg A, Cohen P (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183(1):1\u20139","journal-title":"J Cell Physiol"},{"issue":"3","key":"3891_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","volume":"21","author":"HM Khandwala","year":"2000","unstructured":"Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21(3):215\u2013244","journal-title":"Endocr Rev"},{"issue":"4","key":"3891_CR46","first-page":"1030","volume":"62","author":"Y Wu","year":"2002","unstructured":"Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D (2002) Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62(4):1030\u20131035","journal-title":"Cancer Res"},{"issue":"7","key":"3891_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081844","volume":"9","author":"Y Argon","year":"2020","unstructured":"Argon Y, Bresson SE, Marzec MT, Grimberg A (2020) Glucose-regulated protein 94 (GRP94): a novel regulator of insulin-like growth factor production. Cells 9(7):1844","journal-title":"Cells"},{"issue":"18","key":"3891_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21196995","volume":"21","author":"A Kasprzak","year":"2020","unstructured":"Kasprzak A, Szaflarski W (2020) Role of alternatively spliced messenger RNA (mRNA) isoforms of the insulin-like growth factor 1 (IGF1) in selected human tumors. Int J Mol Sci 21(18):6995","journal-title":"Int J Mol Sci"},{"key":"3891_CR50","doi-asserted-by":"crossref","unstructured":"Simpson A, Petnga W, Macaulay VM, Weyer-Czernilofsky U, Bogenrieder T. (2017). Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies. Targeted oncology, 12(5), 571\u2013597.","DOI":"10.1007\/s11523-017-0514-5"},{"key":"3891_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00058","volume":"11","author":"LD Yee","year":"2020","unstructured":"Yee LD, Mortimer JE, Natarajan R, Dietze EC, Seewaldt VL (2020) Metabolic health, insulin, and breast cancer: why oncologists should care about insulin. Front Endocrinol (Lausanne) 11:58","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7484","key":"3891_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A et al (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505(7484):495\u2013501","journal-title":"Nature"},{"issue":"10","key":"3891_CR53","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","volume":"13","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E, Soares HP, Sinnet-Smith J (2014) Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther 13(10):2477\u20132488","journal-title":"Mol Cancer Ther"},{"key":"3891_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/1471-2407-13-516","volume":"13","author":"SJ Noh","year":"2013","unstructured":"Noh SJ, Bae JS, Jamiyandorj U, Park HS, Kwon KS, Jung SH et al (2013) Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer 13:516","journal-title":"BMC Cancer"},{"issue":"2","key":"3891_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.lungcan.2012.02.016","volume":"77","author":"MS Degese","year":"2012","unstructured":"Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Molinolo A, Hewitt SM et al (2012) Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77(2):168\u2013175","journal-title":"Lung Cancer"},{"issue":"11","key":"3891_CR56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016084","volume":"98","author":"CS Park","year":"2019","unstructured":"Park CS, Eom DW, Ahn Y, Jang HJ, Hwang S, Lee SG (2019) Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma? Medicine (Baltimore) 98(11):e16084","journal-title":"Medicine (Baltimore)"},{"key":"3891_CR57","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2012.02.151","volume":"420","author":"WK Jeon","year":"2012","unstructured":"Jeon WK, Hong HY, Seo WC, Lim KH, Lee HY, Kim WJ, Song SY, Kim BC (2012) Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition. Biochem Biophys Res Commun 420:288\u2013292","journal-title":"Biochem Biophys Res Commun"},{"key":"3891_CR58","first-page":"2145","volume":"30","author":"M Miyake","year":"2010","unstructured":"Miyake M, Fujimoto K, Anai S, Ohnishi S, Nakai Y, Inoue T, Matsumura Y, Tomioka A, Ikeda T, Okajima E, Tanaka N, Hirao Y (2010) Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. Anticancer Res 30:2145\u20132152","journal-title":"Anticancer Res"},{"key":"3891_CR59","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbadis.2013.12.008","volume":"1842","author":"AL Furfaro","year":"2014","unstructured":"Furfaro AL, Piras S, Passalacqua M, Domenicotti C, Parodi A, Fenoglio D, Pronzato MA, Marinari UM, Moretta L, Traverso N, Nitti M (2014) HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. Biochim Biophys Acta 1842:613\u2013622","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3891_CR60","first-page":"1","volume":"21","author":"MH Kazemi","year":"2022","unstructured":"Kazemi MH, Barough MS, Ghanavatinejad A, Momeni-Varposhti Z, Khorrami S, Sadeghi B et al (2022) Decrease of tumor-infiltrating regulatory T cells using pentoxifylline: an ex vivo analysis in triple-negative breast cancer mouse model. Iran J Allergy Asthma Immunol 21(2):1\u201311","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6024","key":"3891_CR61","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559\u20131564","journal-title":"Science"},{"issue":"4","key":"3891_CR62","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16(4):201\u2013218","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3891_CR63","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","volume":"19","author":"L Jin","year":"2018","unstructured":"Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X (2018) Breast cancer lung metastasis: molecular biology and therapeutic implications. Cancer Biol Ther 19(10):858","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"3891_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010618","volume":"16","author":"Q Xin","year":"2022","unstructured":"Xin Q, Lv W, Xu Y, Luo Y, Zhao C, Wang B et al (2022) 2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose\/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis. PLoS Negl Trop Dis 16(7):e0010618","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"3891_CR65","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jbt.21730","volume":"29","author":"L Zhang","year":"2015","unstructured":"Zhang L, Su J, Xie Q, Zeng L, Wang Y, Yi D et al (2015) 2-Deoxy-d-glucose sensitizes human ovarian cancer cells to cisplatin by increasing ER stress and decreasing ATP stores in acidic vesicles. J Biochem Mol Toxicol 29(12):572\u2013578","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"3891_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","volume":"131","author":"B Rowshanravan","year":"2018","unstructured":"Rowshanravan B, Halliday N, Sansom DM (2018) CTLA-4: a moving target in immunotherapy. Blood 131(1):58\u201367","journal-title":"Blood"},{"issue":"4","key":"3891_CR67","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","volume":"78","author":"M Ahlmann","year":"2016","unstructured":"Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78(4):661\u2013671","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"3891_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","volume":"170","author":"DA Yardley","year":"2013","unstructured":"Yardley DA (2013) Nab-paclitaxel mechanisms of action and delivery. J Control Release 170(3):365\u2013372","journal-title":"J Control Release"},{"issue":"16","key":"3891_CR69","first-page":"4355","volume":"54","author":"BH Long","year":"1994","unstructured":"Long BH, Fairchild CR (1994) Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54(16):4355\u20134361","journal-title":"Cancer Res"},{"key":"3891_CR70","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.2147\/DDDT.S97235","volume":"9","author":"H Zhang","year":"2015","unstructured":"Zhang H (2015) Apatinib for molecular targeted therapy in tumor. Drug Des Devel Ther 9:6075\u20136081","journal-title":"Drug Des Devel Ther"},{"key":"3891_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117106","volume":"241","author":"N Fathi Maroufi","year":"2020","unstructured":"Fathi Maroufi N, Rashidi MR, Vahedian V, Akbarzadeh M, Fattahi A, Nouri M (2020) Therapeutic potentials of Apatinib in cancer treatment: possible mechanisms and clinical relevance. Life Sci 241:117106","journal-title":"Life Sci"},{"key":"3891_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","volume":"58","author":"CRC Tan","year":"2019","unstructured":"Tan CRC, Abdul-Majeed S, Cael B et al (2019) Clinical pharmacokinetics and pharmacodynamics of bortezomib. Clin Pharmacokinet 58:157\u2013168","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3891_CR73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","volume":"23","author":"A Korkmaz","year":"2007","unstructured":"Korkmaz A, Topal T, Oter S (2007) Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23(5):303\u2013312","journal-title":"Cell Biol Toxicol"},{"issue":"48","key":"3891_CR74","doi-asserted-by":"publisher","first-page":"17448","DOI":"10.1073\/pnas.0508888102","volume":"102","author":"KV Gurova","year":"2005","unstructured":"Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E et al (2005) Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U S A 102(48):17448\u201317453","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3891_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1172\/JCI33700","volume":"118","author":"KH Maclean","year":"2008","unstructured":"Maclean KH, Dorsey FC, Cleveland JL, Kastan MB (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 118:79\u201388","journal-title":"J Clin Invest"},{"issue":"27","key":"3891_CR76","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1073\/pnas.1903418116","volume":"116","author":"TN Moiseeva","year":"2019","unstructured":"Moiseeva TN, Yin Y, Calderon MJ, Qian C, Schamus-Haynes S, Sugitani N et al (2019) An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proc Natl Acad Sci U S A 116(27):13374\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3891_CR77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.yjmcc.2006.06.009","volume":"41","author":"M Tokarska-Schlattner","year":"2006","unstructured":"Tokarska-Schlattner M, Zaugg M, Zuppinger C, Wallimann T, Schlattner U (2006) New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. J Mol Cell Cardiol 41(3):389\u2013405","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3891_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40487-017-0046-2","volume":"5","author":"MR Nathan","year":"2017","unstructured":"Nathan MR, Schmid P (2017) A review of fulvestrant in breast cancer. Oncol Ther 5(1):17\u201329","journal-title":"Oncol Ther"},{"issue":"7","key":"3891_CR79","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/1078-0432.CCR-12-3072","volume":"19","author":"J Lin","year":"2013","unstructured":"Lin J, Sampath D, Nannini MA, Lee BB, Degtyarev M, Oeh J et al (2013) Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models. Clin Cancer Res 19(7):1760\u20131772","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3891_CR80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia TE, Shulman GI (2021) Cellular and molecular mechanisms of metformin action. Endocr Rev 42(1):77\u201396","journal-title":"Endocr Rev"},{"issue":"7506","key":"3891_CR81","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510(7506):542\u2013546","journal-title":"Nature"},{"issue":"5","key":"3891_CR82","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra040958","volume":"352","author":"JA Meyerhardt","year":"2005","unstructured":"Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352(5):476\u2013487","journal-title":"N Engl J Med"},{"issue":"1","key":"3891_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3747\/co.v18i1.708","volume":"18","author":"T Alcindor","year":"2011","unstructured":"Alcindor T, Beauger N (2011) Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol 18(1):18\u201325","journal-title":"Curr Oncol"},{"issue":"1","key":"3891_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0661-5","volume":"18","author":"RS Finn","year":"2016","unstructured":"Finn RS, Aleshin A, Slamon DJ (2016) Targeting the cyclin-dependent kinases (CDK) 4\/6 in estrogen receptor-positive breast cancers. Breast Cancer Res 18(1):17","journal-title":"Breast Cancer Res"},{"key":"3891_CR85","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1021\/jm800295d","volume":"51","author":"AJ Folkes","year":"2008","unstructured":"Folkes AJ, Ahmadi K, Alderton WK, Alix S, Baker SJ, Box G et al (2008) The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. J Med Chem 51:5522\u20135532","journal-title":"J Med Chem"},{"issue":"1","key":"3891_CR86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/acel.12405","volume":"15","author":"SI Arriola Apelo","year":"2016","unstructured":"Arriola Apelo SI, Neuman JC, Baar EL, Syed FA, Cummings NE, Brar HK et al (2016) Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell 15(1):28\u201338","journal-title":"Aging Cell"},{"issue":"3 Suppl","key":"3891_CR87","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","volume":"35","author":"SN Sehgal","year":"2003","unstructured":"Sehgal SN (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 35(3 Suppl):7S-14S","journal-title":"Transplant Proc"},{"key":"3891_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01990","volume":"10","author":"C Kaegi","year":"2019","unstructured":"Kaegi C, Lutz MB, Hilfiker-Kleiner D, Heikenwalder M (2019) Systematic review of safety and efficacy of Rituximab in treating immune-mediated disorders. Front Immunol 10:1990","journal-title":"Front Immunol"},{"issue":"7","key":"3891_CR89","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1002\/lary.26998","volume":"128","author":"RC Paniello","year":"2018","unstructured":"Paniello RC, Bhatt NK, Chernock R (2018) Toxicity trial of canine posterior cricoarytenoid intramuscular vincristine injections. Laryngoscope 128(7):E247\u2013E250","journal-title":"Laryngoscope"},{"issue":"10","key":"3891_CR90","first-page":"3798","volume":"36","author":"RH Himes","year":"1976","unstructured":"Himes RH, Kersey RN, Heller-Bettinger I, Samson FE (1976) Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res 36(10):3798\u20133802","journal-title":"Cancer Res"},{"issue":"4","key":"3891_CR91","first-page":"1499","volume":"36","author":"RJ Owellen","year":"1976","unstructured":"Owellen RJ, Hartke CA, Dickerson RM, Hains FO (1976) Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res 36(4):1499\u20131502","journal-title":"Cancer Res"},{"issue":"6","key":"3891_CR92","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/odi.12446","volume":"22","author":"SJ Padayatty","year":"2016","unstructured":"Padayatty SJ, Levine M (2016) Vitamin C: the known and the unknown and Goldilocks. Oral Dis 22(6):463\u2013493","journal-title":"Oral Dis"},{"issue":"1","key":"3891_CR93","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3945\/an.113.005157","volume":"5","author":"J Lykkesfeldt","year":"2014","unstructured":"Lykkesfeldt J, Michels AJ, Frei B (2014) Vitamin C. Adv Nutr 5(1):16\u201318","journal-title":"Adv Nutr"},{"issue":"1","key":"3891_CR94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/or.2021.8218","volume":"47","author":"T Shima","year":"2022","unstructured":"Shima T, Taniguchi K, Tokumaru Y, Inomata Y, Arima J, Lee SW et al (2022) Glucose transporter-1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells. Oncol Rep 47(1):7","journal-title":"Oncol Rep"},{"key":"3891_CR95","doi-asserted-by":"crossref","unstructured":"Meng F, Li H, Wang Y, Zheng Z, Chen Y (2025). The mechanism of AKT activation in cancer. Cell Investigation 1;100046","DOI":"10.1016\/j.clnves.2025.100046"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-026-03891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-026-03891-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-026-03891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:08:32Z","timestamp":1781633312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-026-03891-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1007\/s00394-026-03891-2","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"44"}}